Recommendations for the use of cardiac troponin measurement in acute cardiac care†

被引:488
作者
Thygesen, Kristian [1 ]
Mair, Johannes [1 ]
Katus, Hugo [1 ]
Plebani, Mario [1 ]
Venge, Per [1 ]
Collinson, Paul [1 ]
Lindahl, Bertil [1 ]
Giannitsis, Evangelos [1 ]
Hasin, Yonathan [1 ]
Galvani, Marcello [1 ]
Tubaro, Marco [1 ]
Alpert, Joseph S. [1 ]
Biasucci, Luigi M. [1 ]
Koenig, Wolfgang [1 ]
Mueller, Christian [1 ]
Huber, Kurt [1 ]
Hamm, Christian [1 ]
Jaffe, Allan S. [1 ]
机构
[1] Aarhus Univ Hosp, Dept Med & Cardiol, DK-8000 Aarhus C, Denmark
关键词
Cardiac biomarkers; Cardiac troponins; Cardiac troponin I; Cardiac troponin T; Troponin assays; Myocardial infarction; Myocardial necrosis; Myocardial injury; 99th percentile decision level; Troponin assay impression; ACUTE CORONARY SYNDROMES; ACUTE MYOCARDIAL-INFARCTION; STAGE RENAL-DISEASE; MEDICINE PRACTICE GUIDELINES; HIGH-SENSITIVITY ASSAY; PROGNOSTIC VALUE; I ASSAY; MAGNETIC-RESONANCE; 99TH PERCENTILE; CHEST-PAIN;
D O I
10.1093/eurheartj/ehq251
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The release of cardiomyocyte components, i.e. biomarkers, into the bloodstream in higher than usual quantities indicates an ongoing pathological process. Thus, detection of elevated concentrations of cardiac biomarkers in blood is a sign of cardiac injury which could be due to supply-demand imbalance, toxic effects, or haemodynamic stress. It is up to the clinician to determine the most probable aetiology, the proper therapeutic measures, and the subsequent risk implied by the process. For this reason, the measurement of biomarkers always must be applied in relation to the clinical context and never in isolation. There are a large number of cardiac biomarkers, but they can be subdivided into four broad categories, those related to necrosis, inflammation, haemodynamic stress, and/or thrombosis. Their usefulness is dependent on the accuracy and reproducibility of the measurements, the discriminatory limits separating pathology from physiology, and their sensitivity and specificity for specific organ damage and/or disease processes. In recent years, cardiac biomarkers have become important adjuncts to the delivery of acute cardiac care. Therefore, the Working Group on Acute Cardiac Care of the European Society of Cardiology established a committee to deal with ongoing and newly developing issues related to cardiac biomarkers. The intention of the group is to outline the principles for the application of various biomarkers by clinicians in the setting of acute cardiac care in a series of expert consensus documents. The first of these will focus on cardiac troponin, a pivotal marker of cardiac injury/necrosis.
引用
收藏
页码:2197 / 2204B
页数:10
相关论文
共 78 条
[1]   Prevalence of Autoantibodies to Cardiac Troponin T in Healthy Blood Donors [J].
Adamczyk, Maciej ;
Brashear, R. Jeffrey ;
Mattingly, Phillip G. .
CLINICAL CHEMISTRY, 2009, 55 (08) :1592-1593
[2]  
ADAMS JE, 1994, CLIN CHEM, V40, P1291
[3]   National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes [J].
Apple, Fred S. ;
Jesse, Robert L. ;
Newby, L. Kristin ;
Wu, Alan H. B. ;
Christenson, Robert H. ;
Cannon, Christopher P. ;
Francis, Gary ;
Morrow, David A. ;
Ravkilde, Jan ;
Storrow, Alan B. ;
Tang, Wilson ;
Jaffe, Allan S. ;
Mair, Johannes ;
Ordonez-Llanos, Jordi ;
Pagani, Franca ;
Panteghini, Mauro ;
Tate, Jillian .
CLINICAL CHEMISTRY, 2007, 53 (04) :547-551
[4]   A New Season for Cardiac Troponin Assays: It's Time to Keep a Scorecard [J].
Apple, Fred S. .
CLINICAL CHEMISTRY, 2009, 55 (07) :1303-1306
[5]   Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction [J].
Apple, FS ;
Parvin, CA ;
Buechler, KF ;
Christenson, RH ;
Wu, AHB ;
Jaffe, AS .
CLINICAL CHEMISTRY, 2005, 51 (11) :2198-2200
[6]   Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease [J].
Apple, FS ;
Murakami, MM ;
Pearce, LA ;
Herzog, CA .
CIRCULATION, 2002, 106 (23) :2941-2945
[7]   The role of cardiovascular magnetic resonance in patients resenting with chest pain, raised troponin, and unobstructed coronary arteries [J].
Assomull, Ravi G. ;
Lyne, Jonathan C. ;
Keenan, Niall ;
Gulati, Ankur ;
Bunce, Nicholas H. ;
Davies, Simon W. ;
Pennell, Dudley J. ;
Prasad, Sanjay K. .
EUROPEAN HEART JOURNAL, 2007, 28 (10) :1242-1249
[8]   Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients [J].
Babuin, Luciano ;
Vasile, Vlad C. ;
Perez, Jose A. Rio ;
Alegria, Jorge R. ;
Chai, High-Seng ;
Afessa, Bekele ;
Jaffe, Allan S. .
CRITICAL CARE MEDICINE, 2008, 36 (03) :759-765
[9]   Prognostic value of troponins in acute pulmonary embolism - A meta-analysis [J].
Becattini, Cecilia ;
Vedovati, Maria Cristina ;
Agnelli, Giancarlo .
CIRCULATION, 2007, 116 (04) :427-433
[10]  
BELLENGER NG, 2006, J INVASIVE CARDIOL, V8, P594